Skip to main content

Sleep Disorder

1
Pipeline Programs
7
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
1
ABT-652Phase 11 trial
Active Trials
NCT01124851Completed36Est. Apr 2011
Boston Scientific
Boston ScientificCA - Valencia
1 program
Device interrogationN/A1 trial
Active Trials
NCT03614377Unknown600Est. Jul 2022
Fusion Pharmaceuticals Inc.
1 program
Lifestyle InterventionN/A1 trial
Active Trials
NCT03984058CompletedEst. May 2021
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
MelatoninN/A
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
MelatoninN/A1 trial
Active Trials
NCT00795236Terminated13Est. Jun 2015
Bioserenity
BioserenityFrance - Paris
1 program
Memowave emitting soundsN/A1 trial
Active Trials
NCT04875442Withdrawn0Est. Dec 2026
Takeda
TakedaTOKYO, Japan
1 program
RamelteonPHASE_21 trial
Active Trials
NCT00671190Completed75Est. May 2005

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaRamelteon
AbbottABT-652
BioserenityMemowave emitting sounds
Fusion Pharmaceuticals Inc.Lifestyle Intervention
Boston ScientificDevice interrogation
Human BioSciencesMelatonin

Clinical Trials (6)

Total enrollment: 724 patients across 6 trials

NCT00671190TakedaRamelteon

Safety and Efficacy of Ramelteon in Healthy Subjects

Start: Mar 2005Est. completion: May 200575 patients
Phase 2Completed
NCT01124851AbbottABT-652

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

Start: Aug 2010Est. completion: Apr 201136 patients
Phase 1Completed
NCT04875442BioserenityMemowave emitting sounds

Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions

Start: Oct 2023Est. completion: Dec 20260
N/AWithdrawn
NCT03984058Fusion Pharmaceuticals Inc.Lifestyle Intervention

Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes

Start: Oct 2019Est. completion: May 2021
N/ACompleted
NCT03614377Boston ScientificDevice interrogation

DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)

Start: Apr 2017Est. completion: Jul 2022600 patients
N/AUnknown
NCT00795236Human BioSciencesMelatonin

Melatonin Studies of Totally Blind Children

Start: Nov 2009Est. completion: Jun 201513 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.